India clinical trial to evaluate efficacy of glutathione therapy for early Alzheimer's Disease

Titled "Impact of Glutathione (GSH) Supplementation in Mild Cognitive Impairment (MCI) Patients: A Randomized Control Trial", the study is funded by the Department of Biotechnology (DBT), approved by the Drugs Controller General of India and is listed on Clinical Trials Registry-India (CTRI).

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/1XNGE8m
via IFTTT